Grant: Alliance Grants
University of Alberta
$30,000.00
Optimal control algorithm for continuous processes with switching operations
EF 2021-22
Résumé
Drugs based on mAbs play an indispensable role in biopharmaceutical industry in aspects of therapeutic and market potentials. According to a recent publication, mAbs also show promising results in the treatment of COVID-19. Increasing the production capacity of mAb manufacturing processes is immediately necessary due to the explosive growth in mAb market. Replacing the current batch processes by continuous manufacturing processes is recognized as the solution to address the explosive market needs. As we move towards continuous manufacturing in (bio)pharmaceutical, processes with frequent switching operations become more and more common. When to perform the switching between the subprocesses is critical in ensuring product quality and process profitability. The continuous manufacturing of mAb is a representative such process and has attracted much research attention. The proposed project focuses on the optimal control aspect of continuous mAb manufacturing and addresses a particular issue in mAb manufacturing, which has received little attention. Canada is an active and competitive contributor to the development of high capacity mAb manufacturing processes. This project will (a) further enhance the competitiveness of Canada in biopharmaceutical industry, (b) train highly qualified personnel (HQP) that have interdisciplinary backgrounds in biopharmaceutical and control engineering, and (c) create more job opportunities in Quartic.ai in the near future.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
570868-2021
Name nom
Liu, Jinfeng
Department département
Chemical and Materials Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Installment
inst:1
Partie
1
Nb partie
1
Application title
Optimal control algorithm for continuous processes with switching operations
Keyword
NSERC
Application summary
Drugs based on mAbs play an indispensable role in biopharmaceutical industry in aspects of therapeutic and market potentials. According to a recent publication, mAbs also show promising results in the treatment of COVID-19. Increasing the production capacity of mAb manufacturing processes is immediately necessary due to the explosive growth in mAb market. Replacing the current batch processes by continuous manufacturing processes is recognized as the solution to address the explosive market needs. As we move towards continuous manufacturing in (bio)pharmaceutical, processes with frequent switching operations become more and more common. When to perform the switching between the subprocesses is critical in ensuring product quality and process profitability. The continuous manufacturing of mAb is a representative such process and has attracted much research attention. The proposed project focuses on the optimal control aspect of continuous mAb manufacturing and addresses a particular issue in mAb manufacturing, which has received little attention. Canada is an active and competitive contributor to the development of high capacity mAb manufacturing processes. This project will (a) further enhance the competitiveness of Canada in biopharmaceutical industry, (b) train highly qualified personnel (HQP) that have interdisciplinary backgrounds in biopharmaceutical and control engineering, and (c) create more job opportunities in Quartic.ai in the near future.